triazolam 0.25 mg
1 INDICATIONS AND USAGE Triazolam is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. Triazolam is a benzodiazepine indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults.
hikma pharmaceuticals usa inc.
OVAL BLUE 54 620
54 620 OVAL BLUE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
TRIAZOLAM Tablets, USP 0.125 mg tablets are supplied as a white, oval-shaped tablet with tablet identification “54 519” debossed on the one side and plain on the other side. NDC 0054-4858-25: Bottle of 100 Tablets 0.25 mg tablets are supplied as a light blue, oval-shaped tablet, scored on one side with tablet identification “54 620” debossed on the other side. NDC 0054-4859-25: Bottles of 100 Tablets NDC 0054-4859-29: Bottles of 500 Tablets Store at 20º to 25°C (68º to 77°F). [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP/NF.
More pills like OVAL 54 620